Skip to main content
Clinical Trials/NCT02956213
NCT02956213
Completed
Not Applicable

Assessing the Effect of Different Efficiency Indoor Air Filters on Respiratory Symptoms in Former Smokers

Intermountain Health Care, Inc.1 site in 1 country52 target enrollmentNovember 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
Intermountain Health Care, Inc.
Enrollment
52
Locations
1
Primary Endpoint
Change in SGRQ-C score
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The investigators will conduct a randomized, controlled, double-blind, crossover trial to determine whether the presence of a portable high-efficiency indoor air filter in the bedroom reduces respiratory symptoms in former smokers compared with placebo. The primary outcomes will be change in St. George's Respiratory Questionnaire - COPD (SGRQ-C) score associated with using a portable high-efficiency indoor air filter during the study period. Secondary outcomes of COPD exacerbations and hospitalizations, daily step counts, medication changes, spirometry, and cardiovascular outcomes will also be assessed.

Detailed Description

Hypothesis/Research Questions: This study will determine whether the presence of a portable high-efficiency indoor air filter in the bedroom improves respiratory symptoms (based on St. George's Respiratory Questionnaire - COPD - SGRQ-C score) during a period of high air pollution compared with placebo in former smokers with respiratory symptoms. The primary outcome will be the change in SGRQ-C score associated with using a portable high-efficiency indoor air filter during the study period. Secondary outcomes will assess the effect of using a portable high-efficiency indoor air filter on healthcare utilization, other symptom scores, COPD exacerbation frequency, medication use, median daily step counts, inflammatory markers, oxygenation, indoor particulate counts and indoor-outdoor particulate count difference, and pulmonary function tests. Baseline descriptive statistics will report baseline air filter type, duration of use, and particulate weight prior to study enrollment. Evaluation of change in symptom scores and other secondary outcomes from baseline to study air filter (Visit 1 vs. Visit 2).

Registry
clinicaltrials.gov
Start Date
November 2016
End Date
June 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • history of smoking
  • Do not currently smoke and no one currently smokes inside the home
  • history of exacerbation or development of respiratory symptoms (e.g.cough, sputum production, chest tightness, exertional dyspnea, etc.) with periods of high outdoor air pollution ("inversions")
  • Age 40 or older
  • Access to Wi-Fi
  • Access to a cell phone, tablet or personal computer

Exclusion Criteria

  • active tobacco use of subject
  • active tobacco use in the home
  • pre-existing use of a HEPA filter in the subject's bedroom

Outcomes

Primary Outcomes

Change in SGRQ-C score

Time Frame: 12 weeks

based on St. George's Respiratory Questionnaire - COPD - SGRQ-C score

Secondary Outcomes

  • Effect of air filtration on healthcare utilization(6 months)
  • Aggregated assessment of the effect of air filtration on COPD exacerbation frequency(6 months)
  • Change in 6 minute walk test(3 months)
  • Number of cardiovascular events(6 months)
  • Change in median daily step counts(6 months)
  • Change in inflammatory markers(6 months)
  • Change in spirometry(3 months)

Study Sites (1)

Loading locations...

Similar Trials